ADAR1 Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20,840
Closed -$1.98M – 314
2026
Q2
$1.98M Hold
20,840
– – 0.09% 141
2026
Q1
$1.02M Hold
20,840
– – 0.06% 160
2025
Q4
$632K Hold
20,840
– – 0.05% 173
2025
Q3
$401K Sell
20,840
-121,940
-85% -$1.81M 0.04% 151
2025
Q2
$1.6M Buy
142,780
+10,000
+8% +$104K 0.25% 64
2025
Q1
$1.36M Buy
+132,780
New +$1.66M 0.25% 70
2024
Q4
– Sell
-11,187
Closed -$274K – 315
2024
Q3
$274K Buy
11,187
+4,131
+59% +$144K 0.04% 148
2024
Q2
$324K Buy
+7,056
New +$281K 0.06% 123

Other funds holding ORKA

ADAR1 Capital Management's ORKA Position: Q3 2026 in Review

ADAR1 Capital Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 20,840 shares — an estimated $1.98M sold.

ADAR1 Capital Management first reported a position in ORKA in Q2 2024 and held it in 8 quarters. The position peaked at $1.98M in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • ADAR1 Capital Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 20,840 Oruka Therapeutics shares in Q3 2026, an estimated $1.98M.
  • ADAR1 Capital Management first reported a position in Oruka Therapeutics in Q2 2024 and held it in 8 quarters.
  • ADAR1 Capital Management's Oruka Therapeutics position peaked at $1.98M in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.